Concepedia

Author

Nicholas Vlaikidis

Alexion Pharmaceuticals (United States)

Also Known As

N Vlaikidis, N. Vlaikidis, Nicholas Vlaikidis, Thomas Thomaides

7

Publications

1.1K

Citations

6

H-Index

2

Concepts

All Affiliations

Alexion Pharmaceuticals (United States)
NV

About

Nicholas Vlaikidis is an author at Alexion Pharmaceuticals (United States) specializing in medicine and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

745

2

Pharmacology

1

1

745

Nicholas Vlaikidis

×

3

Publications

955

Citations

3

H-Index

YearCitations

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar,

The Lancet Neurology

2017

745

A Randomized, Double-Blind, Placebo-Controlled Study of Venlafaxine XR in Out-Patients With Tension-Type Headache

NP Zissis, S Harmoussi, Nicholas Vlaikidis,

Cephalalgia

2007

106

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold,

Neurology Clinical Practice

2016

104

Page 1